Administer Oyj

ADMIN

FI4000513411

Personal Services

Market Closed - Nasdaq Helsinki Other stock markets 11:17:28 2024-05-08 am EDT			5-day change	1st Jan Change
2.7 ^EUR	+8.00%		+8.00%	+12.03%

Apr. 22	BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment	MT
Apr. 11	Gerresheimer shares down on outlook, but key contracts confirmed	RE

Administer Oyj Reports Earnings Results for the Full Year Ended December 31, 2023

March 07, 2024 at 04:12 pm EST

Administer Oyj reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 75.89 million compared to EUR 52.78 million a year ago. Net loss was EUR 3.89 million compared to EUR 0.703 million a year ago.

Basic loss per share from continuing operations was EUR 0.27 compared to EUR 0.05 a year ago.

Latest news about Administer Oyj

BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment	Apr. 22	MT
Gerresheimer shares down on outlook, but key contracts confirmed	Apr. 11	RE
Administer Plc Announces Audit Committee Appointments	Apr. 10	CI
Administer Plc Announces No Dividend for the Financial Year Ended 31 December 2023	Apr. 10	CI
Scotland's parliament considers assisted dying as poll shows support	Mar. 28	RE
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients	Mar. 26	MT
Reinsurance Group in C$5.8 Billion Coinsurance Deal With Canada's Manulife	Mar. 25	DJ
Administer Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Anima sees net outflows, while Fineco, Mediolanum post inflows	Mar. 06	RE
Administer Oyj Provides Earnings Guidance for 2026	Mar. 06	CI
UK chancellor hopes to reduce tax burden in "prudent" budget	Mar. 03	AN
Eagle Plains And Refined Metals Execute Option Agreement For The Dufferin Uranium Project	Feb. 27	MT
Arch Biopartners on Pre-IND Meeting With FDA to Repurpose Cilastatin as New Treatment to Prevent Acute Kidney Injury	Feb. 27	MT
LG Innotek Sets Up 143 Billion Won Fund for Shared Growth Initiatives in 2024	Feb. 26	MT
Hemogenyx Pharmaceuticals Tests Intranasal Delivery for Viral Infections Treatment	Feb. 14	MT
Hemogenyx says CBR can be used intranasally to treat viral infections	Feb. 14	AN
SAT administrator College Board settles New York claims it sold student data	Feb. 13	RE
Ghana LGBTQ+ activists see church blessings as distant luxury	Feb. 07	RE
Janison Education Signs Deal with NSW Education Department, Cambridge University Press & Assessment; Shares Up 47%	Feb. 05	MT
UK's Hunt wants to "lighten the tax burden" but lowers expectations	Feb. 01	AN
Lilly injection pen for weight-loss drug Mounjaro cleared by British regulator	Jan. 25	RE
Cameroon launches routine malaria shots in global milestone	Jan. 22	RE
Syra Health Wins Contract From Indiana Department of Health; Shares Rise	Jan. 18	MT
Roche Wins EU Nod for Subcutaneous Tecentriq to Treat Various Cancer Types	Jan. 16	MT
Arab neighbours warn against Israeli reoccupation of Gaza	Jan. 10	RE

Chart Administer Oyj

Duration

Period

More charts

Company Profile

Administer Oy is a Finland-based company, that offers financial management and payroll administration services, as well as consultancy and software services. The Companyâs purpose is to transform the financial management services market by developing new technologies and solutions. Administerâs comprehensive offering includes versatile, high-quality financial management services, Human Resources (HR) and payroll management services as well as software services. The Group also offers its customers professional consulting in all its business areas. Administer Oyj is the Group's parent company. The Company has several subsidiaries, including Muonion Taloushallinto Oy, Waasa Profit Counter Oy Ab, Administer Oy Uusimaa as well as Administer Group Services Oy. The Company has a total of 21 offices in Finland, in addition to which it also has offices in Stockholm and Tallinn.

Sector

Personal Services

More about the company